Abstract:Objectives: This article describes the results of a pilot study that used alcohol biomarkers to guide decisions about driving under the influence (DUI) driver risk in the United States, replicating a European best practices model. The pilot tested whether biomarkers (1) can help the assessor identify high-risk drivers who continue to drink heavily after their arrest and (2) detect relapses in drivers enrolled in their drivers' safety plans. Methods: These questions were addressed using two biomarkers, carbohydrate-deficient transferrin (CDT), and the Early Detection of Alcohol Consumption (EDAC) test, to evaluate the drinking behavior in repeat offenders during the assessment interview (baseline) and at 3, 6, 9, and 12 months' follow-up. The cutoff used to determine heavy drinking at baseline was 2.2 percent CDT and 40 percent P-positive for EDAC. A 30 percentage point increase in biomarker value from an abstinent baseline signaled a relapse and a 30 percentage point decrease in biomarker value from a previous positive measure signaled reduced drinking/abstinence. Results: The results show that the EDAC used alone identified 18 percent of drivers as heavy drinkers at baseline compared to 5 percent for CDT and 8 percent for GGT. The best detection rate was achieved with the EDAC-CDT combination, which captured heavy drinking in 20 percent of the repeat offenders at baseline, most of whom (68%) denied drinking at the assessment interview. During follow-up, 52 percent of drivers abstained/reduced their drinking, almost 20 percent experienced a relapse, and 30 percent remained noncompliant with testing. Drivers who relapsed were less likely to be employed full-time (67 versus 84%) or married (17 versus 30%) compared to those who abstained. Of the drivers who relapsed, 80 percent returned to abstinence or reduced their drinking after biomarker information was used as brief intervention by the counselors. Conclusion: Biomarker testing improved the assessment and monitoring of repeat offenders in this pilot because it provided an objective tool to identify high-risk drivers allowing for better treatment recommendations and helped identified drivers who relapsed during follow-up to facilitate a brief intervention by the counselor that resulted in reduced alcohol consumption. These results contribute to establish evidence based practices in highway safety and are setting up new guidelines in the United States to reduce drunk driving.

Delays in blood collection and drug toxicology results among crash-involved drivers arrested for impaired driving

Toxicology findings from drivers suspected of drug-impaired driving in Ontario (2008–2019)

Potential Analytical Methods for On-Site Oral Drug Test: Recent Developments and Applications

Four-year evaluation of drug-impaired driving drug concentrations

Case management in a DUI lab: effect on drugs reported

A two-year review of cocaine findings in impaired driving investigations in Ontario, Canada

The relationship between clinical impairment and blood drug concentration: Comparison between the most prevalent traffic relevant drug groups

Driving impairment and altered ocular activity under the effects of alprazolam and alcohol: A randomized, double-blind, placebo-controlled study

Alcohol biomarkers as tools to guide and support decisions about intoxicated driver risk

Psychosocial characteristics and follow-up of drinking and non-drinking drivers in motor vehicle crashes

An integrated spatio-temporal approach to examine the consequences of driving under the influence (DUI) in crashes

Tolerant or Intolerant? Learning From Studying Drug Concentrations in the Living and the Dead

Driving under the influence of cocaine and MDMA: Relationship between blood concentrations and results from clinical test of impairment

Speeding and impaired driving in fatal crashes-Results from in-depth investigations

Blood alcohol concentration in the clinical laboratory: a narrative review of the preanalytical phase in diagnostic and forensic testing

What contributes to drug driving? An exploratory investigation into the influence of problematic substance use, roadside testing and alternative transport options

Statistical Analysis of Toxicological Data of Victims of Traffic Accidents in Galicia (Spain)

The Effect of Alcohol on the Physiological Performance of the Driver

Relapse of drunk driving and association with traffic accidents, alcohol-related problems and biomarkers of impulsivity

Study of the Effects of Alcohol on Drivers and Driving Performance on Straight Road

Drinking and Driving in the United States: Comparing Results from the 2007 and 1996 National Roadside Surveys.